Be Ready to Help Your Crohn's Disease Patients Start Biologics

July 2018

You'll see biologics considered earlier for Crohn's disease...partly due to new guidelines from the Am College of Gastroenterology.

This "top-down" approach is becoming more popular...versus waiting to see if meds such as sulfasalazine, mesalamine, or corticosteroids help.

For Crohn's, anticipate seeing infliximab (Remicade), adalimumab (Humira), certolizumab (Cimzia), vedolizumab (Entyvio), etc. These can lead to faster and longer-lasting remission for some higher-risk patients.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Infectious Diseases Ensure Patients With Gonorrhea Get Two Antibiotics
Anticoagulants Watch for Andexxa, a New Anticoagulant Reversal Agent
Diabetes Don't Use a Flozin Plus a GLP-1 Agonist for Most Diabetes Patients
Aspirin Put the Aspirin and NSAID Interaction in Perspective
Sunscreens Help Balance Competing Concerns About Sunscreens
Stroke Optimize Meds to Reduce Recurrent Stroke Risk
Crohn's Disease Be Ready to Help Your Crohn's Disease Patients Start Biologics
Women's Health Any OTC Levonorgestrel Product Is Okay for Emergency Contraception
Practice Set Patient Expectations for Home Genetic Tests
Respiratory & Allergy Don't Jump to Xhance for Nasal Polyps
Vaginal Infections Stick With Metronidazole for Most Women With Bacterial Vaginosis
Communication Improve Communication With Older Patients
Stroke Be Aware of the Latest Evidence With Acute Stroke Protocols
Practice Look for New Opportunities for IV-to-PO Conversions

Be Ready to Help Your Crohn's Disease Patients Start Biologics

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents